Our Approach
Pipeline & Targets
Our People
Patients
For Investors
Select Page
Kelleen Chea
by
tyraadmin
|
Jun 23, 2021
Alexandra Balcer
by
tyraadmin
|
Jun 11, 2021
Corbin Occhino
by
tyraadmin
|
Jun 11, 2021
Kirk Nelson
by
tyraadmin
|
Jun 11, 2021
Melissa Ye
by
tyraadmin
|
Jun 11, 2021
« Older Entries
Next Entries »
Search for:
Recent News
Tyra Biosciences raises $106M in Series B financing to advance novel pipeline of therapies targeting acquired resistance in oncology
Tyra Biosciences raises $50M to develop therapies targeting acquired resistance in oncology
Categories
Fundraising
